收费全文 | 5361篇 |
免费 | 246篇 |
国内免费 | 101篇 |
耳鼻咽喉 | 33篇 |
儿科学 | 258篇 |
妇产科学 | 161篇 |
基础医学 | 238篇 |
口腔科学 | 139篇 |
临床医学 | 607篇 |
内科学 | 602篇 |
皮肤病学 | 65篇 |
神经病学 | 360篇 |
特种医学 | 127篇 |
外科学 | 636篇 |
综合类 | 649篇 |
一般理论 | 1篇 |
预防医学 | 791篇 |
眼科学 | 83篇 |
药学 | 449篇 |
6篇 | |
中国医学 | 160篇 |
肿瘤学 | 343篇 |
2023年 | 121篇 |
2022年 | 121篇 |
2021年 | 226篇 |
2020年 | 234篇 |
2019年 | 147篇 |
2018年 | 165篇 |
2017年 | 146篇 |
2016年 | 151篇 |
2015年 | 146篇 |
2014年 | 409篇 |
2013年 | 388篇 |
2012年 | 299篇 |
2011年 | 332篇 |
2010年 | 258篇 |
2009年 | 273篇 |
2008年 | 259篇 |
2007年 | 234篇 |
2006年 | 190篇 |
2005年 | 187篇 |
2004年 | 149篇 |
2003年 | 127篇 |
2002年 | 109篇 |
2001年 | 100篇 |
2000年 | 88篇 |
1999年 | 85篇 |
1998年 | 75篇 |
1997年 | 56篇 |
1996年 | 59篇 |
1995年 | 53篇 |
1994年 | 45篇 |
1993年 | 43篇 |
1992年 | 45篇 |
1991年 | 41篇 |
1990年 | 36篇 |
1989年 | 35篇 |
1988年 | 35篇 |
1987年 | 30篇 |
1986年 | 36篇 |
1985年 | 34篇 |
1984年 | 26篇 |
1983年 | 11篇 |
1982年 | 18篇 |
1981年 | 19篇 |
1980年 | 15篇 |
1979年 | 10篇 |
1978年 | 7篇 |
1977年 | 8篇 |
1976年 | 9篇 |
1975年 | 10篇 |
1974年 | 3篇 |
Aims
The 2014 British Thyroid Association thyroid cancer guidelines recommend lifelong follow-up of thyroid cancer patients. This is probably unnecessary, can cause patient anxiety, is time consuming and places significant demand on National Health Service resources. It has been suggested that low-risk differentiated thyroid cancer (DTC) patients could be discharged to primary care once they are 5 years from diagnosis and treatment. The aim of this study was to investigate the potential safety of this practice.Materials and methods
In total, 756 patients with dynamically risk-stratified (DRS) low-risk/excellent response to treatment DTC treated over 2001–2013 in the Leeds region were followed after diagnostic surgery and the recurrence rate calculated.Results
The median follow-up time was nearly 10 years (5–17 years). Radiological recurrence occurred in 13/756 (1.7%) patients and was always preceded by raised thyroglobulin/ thyroglobulin antibody levels. In all 13 patients elevation of thyroglobulin occurred within 5 years of diagnosis. Two additional patients were found to have rising thyroglobulin at almost 9 and 10.5 years from diagnosis, although to date radiological recurrence has not been detected. Assuming these two patients developed recurrence with longer duration of follow-up, then 0.26% (2/756) of patients would not have their recurrence discovered within 5 years of diagnosis. To detect 100% of patients with a putative recurrence in our cohort would require 10.5 years of follow-up. Four patients had transiently raised thyroglobulin, which became undetectable within 2 years (in three patients), without any treatment and radiological recurrence was not discovered.Conclusion
Discharge of DRS low-risk DTC patients to primary care after 5 years of secondary care follow-up is reasonable, accepting that late recurrence may occur in a very small minority of individuals (0.26%, ~1:400). A more cautious approach would be to continue monitoring for 10 years, although the frequency of assessments could be reduced with increasing duration of follow-up. 相似文献Materials and methods: From 2011 to 2013, we recruited 231 primary cerebral infarct patients that were divided to a Hhcy group (n?=?105) and a control group (n?=?126) according to plasma homocysteinemia (Hcy) levels exceeding 15?μmol/L. In this prospective study, risk factors such as gender, age, blood lipid and glucose levels, history of diabetes, high blood pressure, smoking habits and plasma Hhcy levels were determined. A three-year follow-up compared differences in cerebral infarction recurrence rates. Statistical analyses identified whether plasma Hhcy levels were an independent risk factor for recurrent cerebral infarction.
Results: Triglyceride and low-density lipoprotein (LDL) levels in the Hhcy group were significantly higher than controls, and cerebral infarct recurrence rates in the Hhcy group exceeded control subject rates through the three-year follow-up (p?=?.021, p?=?.036 and p?=?.025). Cox proportional hazards modeling showed that elevated Hhcy levels (hazard ratio [HR]?=?3.062, p?<?.001), increased age (HR?=?1.069, p?<?.01), circulating triglyceride levels (HR?=?1.686, p?=?.048), and relative National Institutes of Health Stroke (NIHSS) score (HR?=?1.068, p?=?.016) were risk factors for recurrent cerebral infarction.
Conclusions: Level of Hhcy was a risk factor for recurrent cerebral infarction. Further, particular demographic and clinical outcomes including age, relative NIHSS scores, and circulating triglyceride levels were markedly associated with the occurrence of cerebral infarction. 相似文献